OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant and neoadjuvant therapies for hepatocellular carcinoma
Arndt Vogel, Robert C. Grant, Tim Meyer, et al.
Hepatology (2023)
Closed Access | Times Cited: 14

Showing 14 citing articles:

Immunotherapy for hepatocellular carcinoma
Alexa Childs, Gloryanne Aidoo-Micah, Mala K. Maini, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101130-101130
Closed Access | Times Cited: 12

Precision surgery for hepatocellular carcinoma
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 1

Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma
Juan Jose Urquijo-Ponce, Carlos Alventosa-Mateu, Mercedes Latorre-Sánchez, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 19, pp. 2512-2522
Open Access | Times Cited: 6

S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 02, pp. e82-e158
Closed Access

S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 03, pp. e159-e260
Closed Access

Molecular Testing and Targeted Therapies in Hepatobiliary Cancers
Diamantis I. Tsilimigras, Razelle Kurzrock, Timothy M. Pawlik
JAMA Surgery (2025)
Closed Access

Proposal for Prognosis-Oriented Definition of Borderline Resectable Hepatocellular Carcinoma
Koichiro Haruki, Norifumi Harimoto, Kenei Furukawa, et al.
Journal of the American College of Surgeons (2024) Vol. 238, Iss. 6, pp. 1137-1147
Closed Access | Times Cited: 2

Approach to immunotherapy for HCC in the liver transplant population
Peter D. Block, Mario Strazzabosco, Ariel Jaffe
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2

Hepatocellular carcinoma systemic treatment 2024 update: from early to advanced stage
Wei Teng, T-H Wu, Shi‐Ming Lin
Biomedical Journal (2024), pp. 100815-100815
Open Access | Times Cited: 1

Liver Transplantation for Hepatocellular Carcinoma: An Expanding Cornerstone of Care in the Era of Immunotherapy
Christian Tibor Josef Magyar, Grainne M. O’Kane, Laia Aceituno, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 1

Improving gastrointestinal cancer therapy by uniting stakeholders
Michael Quante, Anna Saborowski, C. Benedikt Westphalen
ESMO Gastrointestinal Oncology (2024) Vol. 3, pp. 100040-100040
Open Access

Preoperative predictors of very early recurrence in patients with hepatocellular carcinoma beyond the Milan criteria
Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, et al.
Langenbeck s Archives of Surgery (2024) Vol. 409, Iss. 1
Closed Access

Cell therapy using anti-NKG2A pretreated natural killer cells in patients with hepatocellular carcinoma
Saeed Nazari Tavakoli, Maryam Samareh Salavatipour, Shahrokh Abdolahi, et al.
Advanced Pharmaceutical Bulletin (2024)
Open Access

Page 1

Scroll to top